Sales and Marketing

Showing 15 posts of 11524 posts found.

Astellas eyes oncology growth

April 21, 2010 Research and Development, Sales and Marketing Astellas, Astellas Pharma Europe

Astellas Pharma Europe has set its sights on the oncology market, earmarking the therapy area as its latest “franchise focus” …

Secondary endpoints failure take shine off Benlysta

April 21, 2010 Sales and Marketing GSK, HGS, Lupus

GlaxoSmithKline’s lupus treatment has failed to reach a statistically significant secondary endpoint in the second of two phase III trials. …
UCF 010310

Wyeth’s Ursula Franklin joins Red Kite

April 21, 2010 Business Services, Sales and Marketing Red Kite, appointment, coaching, development, leadership, sales and marketing, strategic planning, strategy, training

Red Kite has appointed Ursula Franklin to head up its new Transformation division. She joins from Wyeth Europa, now part …

GSK’s Arzerra conditionally approved in Europe

April 20, 2010 Research and Development, Sales and Marketing Arzerra, GSK, leukaemia

GlaxoSmithKline’s orphan cancer treatment Arzerra has been given conditional marketing authorisation in the European Union. Arzerra (ofatumumab) can be used …

Emerging markets and generics poised to drive pharma growth

April 20, 2010 Sales and Marketing IMS, em, emerging markets

The global pharma market will reach $1.1 trillion in 2014 through growth primarily driven by emerging markets and generics, according …

Lilly faces substantial costs from US health reform

April 20, 2010 Sales and Marketing 2010 financials, Obama, lilly

Lilly expects to lose up to $485 million this year as a direct result of the US healthcare reforms, but …

ABPI appoints Roche’s Paul Catchpole

April 20, 2010 Sales and Marketing ABPI, UK, appointment, sales and marketing

UK industry association the ABPI has appointed Paul Catchpole as director of value and access. He will join the association …

Novartis set to boost generic portfolio

April 19, 2010 Sales and Marketing Novartis, Sandoz, generics

Novartis’ generics arm Sandoz has signed a deal to acquire US-based inhalable drug specialist Oriel Therapeutics. Sandoz will gain rights …

Genzyme appoint investor to outmanoeuvre Icahn

April 16, 2010 Sales and Marketing Contamination, Genzyme

Genzyme has appointed the head of one of its biggest shareholders to its board in order to block a hostile …
Roche's China operations

Emerging markets lift Roche in Q1

April 16, 2010 Sales and Marketing Roche, emerging markets

Roche saw its sales grow 9% overall in the first quarter, with emerging markets medicines revenues showing a healthy 38% …

Cephalon completes acquisition of generics firm Mepha

April 16, 2010 Sales and Marketing Cephalon, generics

Specialist pharmaceutical company Cephalon has completed the $615.4 million acquisition of Mepha. Based in Switzerland, Mepha specialises in using reformulation …

Hikma expands in Middle East & North Africa

April 15, 2010 Manufacturing and Production, Sales and Marketing Hikma, em

UK-headquartered Hikma Pharmaceuticals has signed a flurry of deals that expand its position in the fast-growing Middle East and North …
FredHassan

Fred Hassan moves to Bausch & Lomb

April 15, 2010 Sales and Marketing Bausch and Lomb, appointment, sales and marketing

Pharma industry veteran Fred Hassan has been appointed chairman at eye health company Bausch & Lomb. Hassan was previously chairman …

Abbott chief exec ordered to hand over email records

April 14, 2010 Sales and Marketing Abbott, conduct

A US judge has ordered Abbott to give prosecutors access to company emails, including those sent by chief executive Miles …

Patients ignorant of blood clot risks

April 14, 2010 Sales and Marketing Pradaxa, VTE, thrombosis

Many patients are not aware that they are at risk from blood clots when staying in hospital, according to new …
The Gateway to Local Adoption Series

Latest content